Early identification of weight loss trajectories in advanced cancer and associations with survival
JNCI: Journal of the National Cancer Institute · 2025
DOI: 10.1093/jnci/djaf030 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Sophia Fuller und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Research, Kaiser Permanente Northern California, Pleasanton, CA 94588, United States. Hauptthemen laut MEDLINE: Weight Loss, Cachexia, Neoplasms, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute and Cancer Research, Cancer Grand Challenges.
Abstract (Originalsprache)
Consensus criteria to diagnose unintentional weight loss, a condition often termed cachexia that affects most patients with advanced cancer, are based on 6-month changes by which time intervention is often ineffective. Leveraging the large and diverse population in Kaiser Permanente Northern California’s community oncology practice, we studied 8338 patients with advanced lung, pancreatic, or colorectal cancers. We calculated weekly weight change measurements from 2 months pre- to 6 months post-diagnosis to identify 4 weight change trajectories (Gain, Stable, Moderate Loss, and Severe Loss) and associated these trajectories with survival. With high agreement, we classified patients into these trajectories after 3 months and found them to be prognostic; those classified in Moderate (HR = 1.55; 95% CI = 1.45 to 1.67) or Severe Loss (HR = 2.20; 95% CI = 2.01 to 2.41) at 3 months had significantly increased risk of death compared with the Stable trajectory. Weight loss at 3 months post-diagnosis can accurately classify deleterious weight trajectories, allowing for earlier clinical intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Research, Kaiser Permanente Northern California, Pleasanton, CA 94588, United States.
- Department of Medicine, NYU Langone Health, New York, NY 10016, United States.
- Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY 14642, United States.
- Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY 11724, United States.
- Northwell Health Cancer Institute, Northwell Health, New Hyde Park, New York, NY 11042, United States.
- Cancer Research UK Lung Cancer Centre of Excellence and Cancer Metastasis Laboratory, University College London Cancer Institute, London WC1E 6BT, United Kingdom.
ORCID-Profile: Sophia Fuller, Stacey Alexeeff, Bette Caan, Marcus D Goncalves, Richard F Dunne, Tobias Janowitz, Mariam Jamal-Hanjani, Elizabeth M Cespedes Feliciano
Förderung
- NCI NIH HHS
- National Cancer Institute and Cancer Research
- Cancer Grand Challenges
- NIH
Zitieren
APA
Fuller, S., Alexeeff, S., Caan, B., Goncalves, M. D., Dunne, R. F., Janowitz, T., Jamal-Hanjani, M., Sundaresan, T. K., & Cespedes Feliciano, E. M. (2025). Early identification of weight loss trajectories in advanced cancer and associations with survival. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf030
Vancouver
Fuller S, Alexeeff S, Caan B, Goncalves MD, Dunne RF, Janowitz T, et al. Early identification of weight loss trajectories in advanced cancer and associations with survival. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djaf030
BibTeX
@article{Fuller2025,
author = {Fuller, Sophia and Alexeeff, Stacey and Caan, Bette and Goncalves, Marcus D and Dunne, Richard F and Janowitz, Tobias and Jamal-Hanjani, Mariam and Sundaresan, Tilak K and Cespedes Feliciano, Elizabeth M},
title = {Early identification of weight loss trajectories in advanced cancer and associations with survival},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2025},
doi = {10.1093/jnci/djaf030}
}
EUVIMED